Jorveza 0.5 mg orodispersible tablets

Licence status
Authorised: 20/05/2020
Active substances
Budesonide
Dosage Form
Orodispersible tablet
Licence number
EU/1/17/1254/007-011
Licence holder
Dr. Falk Pharma GmbH

Product documents

Licence information

ATC code
A07EA06 budesonide
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
20/05/2020